- 期刊
β-Arrestin-1-Dependent Activation of Extracellular Signal-Regulated Kinases in RON Receptor-Mediated Tumorigenic Activities in Colon Cancer Cells
並列摘要
AIM: β-Arrestin-1 is an adaptor protein essential in G-protein-coupled receptor signaling and function. Recently, a mechanism by which β-arrestin-1 acted as a scaffolding molecule that regulated signaling pathways of receptor tyrosine kinases was discovered. The goal of this study is to determine the roles of β-arrestin-1 in RON-activated MAP kinase signaling that regulates tumorigenic activities of colon cancer cells.METHODS: Immunohistochemistry of tumor tissue arrays was used to determine RON and β-arrestin-1 expression. Immunoprecipitation and Western blotting were used to determine protein interaction and phosphorylation. Specific siRNA was used to silence β-arrestin-1 gene expression. Cell growth, transformation, and migration were determined by proliferation, focus formation and migration assays.RESULTS: Overexpression of RON (52/88 cases, 59.1%) in primary colon cancer samples was significantly matched with β-arrestin-1 expression. In 52 samples with RON overexpression, β-arrestin-1 was co-expressed in 41 cases (46.6%). In colon cancer HT-29 and other cells, β-arrestin-1 formed a signaling protein complex with RON and c-Src. RON-mediated dephosphorylation of β-arrestin-1 at Ser-412 increased their interaction. Silencing of β-arrestin-1 gene expression by siRNA techniques impaired RON-mediated Erk1/2 phosphorylation but had no effect on AKT phosphorylation. The β-arrestin-1 gene disruption also blocked oncogenic RON160-mediated cellular transformation in rodent fibroblast and colonic epithelial cells. Moreover, silencing β-arrestin-1 gene expression significantly reduced RON agonistic mAb Zt/c1-induced colon cancer cell proliferation but not migration.CONCLUSION: β-Arrestin-1 was selectively involved in RON-transduced signals. The requirement of β-arrestin-1 in MAP kinase signaling shed light on the mechanisms by which RON regulated malignancy of colon cancer cells.
被引用紀錄
延伸閱讀
- 陳彥羽（2019）。The role and molecular mechanism of Timosaponin AIII inhibit metastasis of renal carcinoma cells〔碩士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/CSMU201900148
- An, X. (2007). Functional characterization of cell-cycle related kinase(CCRK) in glioblastoma and colon cancer carcinogenesis [doctoral dissertation, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200012489
- 周軒宇（2011）。Inhibition of epithelial-mesenchymal transition regulator Slug enhances doxorubicin-induced apoptosis in drug resistant MCF-7/ADR cells〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2011.02758
- Che, M. I. (2014). β1,4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2014.00235
- Lee, C. Y., Marzan, D., Lin, G., Goodison, S., & Silletti, S. (2011). α2 Integrin-Dependent Suppression of Pancreatic Adenocarcinoma Cell Invasion Involves Ectodomain Regulation of Kallikrein-Related Peptidase-5. Journal of Oncology, 2011(), 20-34. https://doi.org/10.1155/2011/365651